|
Q3 FY2026
As of Aug 31, 2026
|
Q2 FY2026
As of May 31, 2026
|
Q1 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Nov 30, 2025
|
Q3 FY2025
As of Aug 31, 2025
|
Q2 FY2025
As of May 31, 2025
|
Q1 FY2025
As of Feb 28, 2025
|
Q4 FY2024
As of Nov 30, 2024
|
Q3 FY2024
As of Aug 31, 2024
|
Q2 FY2024
As of May 31, 2024
|
Q1 FY2024
As of Feb 29, 2024
|
Q4 FY2023
As of Nov 30, 2023
|
Q3 FY2023
As of Aug 31, 2023
|
Q2 FY2023
As of May 31, 2023
|
Q1 FY2023
As of Feb 28, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Restricted cash, end of period | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Marketable debt securities | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| LONG TERM ASSETS | ||||||||||||||||||||
| Deposits for equipment | ||||||||||||||||||||
| Right-of-use-assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investment in joint venture | ||||||||||||||||||||
| Loan to joint venture | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| LONG TERM LIABILITIES | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Contingent consideration, non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued | ||||||||||||||||||||
| Total preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued | ||||||||||||||||||||
| Common stock, $0.001 par value, 50,000,000 shares authorized. 26,043,337 shares issued and 23,404,754 shares outstanding as of August 31, 2026, and 25,258,393 shares issued and 22,678,715 outstanding as of November 30, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock (2,638,583 and 2,579,678 shares purchased as of August 31, 2026 and November 30, 2025, respectively) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
